[1]
2025. IMPLEMENTATION OF TARGET THERAPY IN RELAPSED CLASSIC HODGKIN LYMPHOMA: A SINGLE-CENTER EXPERIENCE. Herald of the National Children’s Medical Center. (May 2025), 148–150.